Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03829111 |
|---|---|
| Brief Title: | CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer |
| First Submitted : | February 1, 2019 |
| First Submitted that Met QC Criteria : | February 1, 2019 |
| First Posted : | February 4, 2019 |
| Last Update Submitted that Met QC Criteria : | December 28, 2023 |
| Last Update Posted : | January 2, 2024 |